Dette burde være bull.
Skaper forhåpentligvis ett gulv/støttenivå på 4.

Radforsk Investeringsstiftelse has on 27 September 2024 sold 7 500 000 shares in Nykode Therapeutics ASA (the "Company"). Following this transaction, Radforsk Investeringsstiftelse holds 10 315 311 shares in the Company, corresponding to 3.16% of the total number of issued shares in the Company, and thereby reducing its ownership below the 5% disclosure threshold set out in the Norwegian Securities Trading Act Section 4-2. The proceeds from this transaction will be used to settle Radforsks bank loan in full.

https://newsweb.oslobors.no/message/628664